Literature DB >> 23145205

EZH2: a pivotal regulator in controlling cell differentiation.

Ya-Huey Chen1, Mien-Chie Hung, Long-Yuan Li.   

Abstract

Epigenetic regulation plays an important role in stem cell self-renewal, maintenance and lineage differentiation. The epigenetic profiles of stem cells are related to their transcriptional signature. Enhancer of Zeste homlog 2 (EZH2), a catalytic subunit of epigenetic regulator Polycomb repressive complex 2 (PRC2), has been shown to be a key regulator in controlling cellular differentiation. EZH2 is a histone methyltransferase that not only methylates histone H3 on Lys 27 (H3K27me3) but also interacts with and recruits DNA methyltransferases to methylate CpG at certain EZH2 target genes to establish firm repressive chromatin structures, contributing to tumor progression and the regulation of development and lineage commitment both in embryonic stem cells (ESCs) and adult stem cells. In addition to its well-recognized epigenetic gene silencing function, EZH2 also directly methylates nonhistone targets such as the cardiac transcription factor, GATA4, resulting in attenuated GATA4 transcriptional activity and gene repression. This review addresses recent progress toward the understanding of the biological functions and regulatory mechanisms of EZH2 and its targets as well as their roles in stem cell maintenance and cell differentiation.

Entities:  

Keywords:  EZH2; adult stem cells; chromatin modification; embryonic stem cells; methylation; polycomb repressive complex

Year:  2012        PMID: 23145205      PMCID: PMC3493026     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  100 in total

Review 1.  Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.

Authors:  Martin Sauvageau; Guy Sauvageau
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

Review 2.  Polycomb group proteins set the stage for early lineage commitment.

Authors:  Lauren E Surface; Seraphim R Thornton; Laurie A Boyer
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

Review 3.  Interpretation of developmental signaling at chromatin: the Polycomb perspective.

Authors:  Ritwick Sawarkar; Renato Paro
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

Review 4.  Epigenetic modifications in pluripotent and differentiated cells.

Authors:  Alexander Meissner
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

5.  Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.

Authors:  Syuzo Kaneko; Gang Li; Jinsook Son; Chong-Feng Xu; Raphael Margueron; Thomas A Neubert; Danny Reinberg
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

6.  Long noncoding RNA as modular scaffold of histone modification complexes.

Authors:  Miao-Chih Tsai; Ohad Manor; Yue Wan; Nima Mosammaparast; Jordon K Wang; Fei Lan; Yang Shi; Eran Segal; Howard Y Chang
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

7.  CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.

Authors:  Yongkun Wei; Ya-Huey Chen; Long-Yuan Li; Jingyu Lang; Su-Peng Yeh; Bin Shi; Cheng-Chieh Yang; Jer-Yen Yang; Chun-Yi Lin; Chien-Chen Lai; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2010-12-05       Impact factor: 28.824

8.  Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.

Authors:  Shuai Chen; Laura R Bohrer; Aswathy N Rai; Yunqian Pan; Lu Gan; Xianzheng Zhou; Anindya Bagchi; Jeffrey A Simon; Haojie Huang
Journal:  Nat Cell Biol       Date:  2010-10-10       Impact factor: 28.824

9.  The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.

Authors:  Liudmila L Kodach; Rutger J Jacobs; Jarom Heijmans; Carel J M van Noesel; Alexandra M J Langers; Hein W Verspaget; Daniel W Hommes; G Johan A Offerhaus; Gijs R van den Brink; James C H Hardwick
Journal:  Carcinogenesis       Date:  2010-07-14       Impact factor: 4.944

10.  TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration.

Authors:  Daniela Palacios; Chiara Mozzetta; Silvia Consalvi; Giuseppina Caretti; Valentina Saccone; Valentina Proserpio; Victor E Marquez; Sergio Valente; Antonello Mai; Sonia V Forcales; Vittorio Sartorelli; Pier Lorenzo Puri
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

View more
  23 in total

Review 1.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

Review 2.  Diverse involvement of EZH2 in cancer epigenetics.

Authors:  Pamela Völkel; Barbara Dupret; Xuefen Le Bourhis; Pierre-Olivier Angrand
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.

Authors:  Yemin Wang; Shary Yuting Chen; Anthony N Karnezis; Shane Colborne; Nancy Dos Santos; Jessica D Lang; William Pd Hendricks; Krystal A Orlando; Damian Yap; Friedrich Kommoss; Marcel B Bally; Gregg B Morin; Jeffrey M Trent; Bernard E Weissman; David G Huntsman
Journal:  J Pathol       Date:  2017-06-02       Impact factor: 7.996

4.  EZH2 promotes neoplastic transformation through VAV interaction-dependent extranuclear mechanisms.

Authors:  N Venkatesan; J F Wong; K P Tan; H H Chung; Y H Yau; E Cukuroglu; A Allahverdi; L Nordenskiöld; J Göke; S Geifman-Shochat; V C L Lin; M S Madhusudhan; I-H Su
Journal:  Oncogene       Date:  2017-10-02       Impact factor: 9.867

5.  Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the β-catenin gene.

Authors:  Murielle M Akpa; Diana M Iglesias; Lee Lee Chu; Marta Cybulsky; Cristina Bravi; Paul R Goodyer
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

6.  Inhibiting EZH2 rescued bupivacaine-induced neuronal apoptosis in spinal cord dorsal root ganglia in mice.

Authors:  Jinwei Zheng; Junping Chen; Guorong Wu; Chaoshuang Wu; Ruichun Wang; Wei Wang
Journal:  J Anesth       Date:  2018-05-11       Impact factor: 2.078

7.  An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

Authors:  Kyle D Konze; Anqi Ma; Fengling Li; Dalia Barsyte-Lovejoy; Trevor Parton; Christopher J Macnevin; Feng Liu; Cen Gao; Xi-Ping Huang; Ekaterina Kuznetsova; Marie Rougie; Alice Jiang; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Bryan L Roth; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Klaus M Hahn; Gang Greg Wang; Masoud Vedadi; Jian Jin
Journal:  ACS Chem Biol       Date:  2013-04-24       Impact factor: 5.100

8.  Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.

Authors:  Qiwei Yang; Archana Laknaur; Lelyand Elam; Nahed Ismail; Larisa Gavrilova-Jordan; John Lue; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2016-03-31       Impact factor: 3.060

9.  The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression.

Authors:  Zhili Liu; Ming Sun; Kaihua Lu; Jing Liu; Meiling Zhang; Weiqin Wu; Wei De; Zhaoxia Wang; Rui Wang
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

10.  3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.

Authors:  Nicolas Girard; Céline Bazille; Eva Lhuissier; Hervé Benateau; Antonio Llombart-Bosch; Karim Boumediene; Catherine Bauge
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.